Food and Drug Administration has approved Ozempic (semaglutide) to reduce the risk of kidney disease worsening, kidney failure, and death due to cardiovascular disease for adults living with type 2 diabetes and chronic kidney disease
Although borderline cost-effective against placebo (ICER: $39,853.22/QALY), the overall price of oral semaglutide remains high, underscoring the importance of reasonable drug pricing to improve access to medical resources
Sofwave Areas of Treatment Skin laxity face, neck, and chin (submental area) Wrinkles associated with loose skin face, neck, and chin (submental area) Crepey skin arms Non-tethered acne scars face Cellulite related to loose skin legs, buttocks Sofwave Compared to Other Ultrasound Therapies: Whats the Difference
"Triple-hormone-receptor agonist retatrutide for obesity - a phase 2 trial." The New England Journal of Medicine, 2023
The GI side effects and hormonal disruption from combining a dual and triple agonist would be significant and unpredictable
Incorporate them into meals for a nutritious option that supports weight management and metabolic health
